CROX
Crocs Inc
124.60$
+0.0%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 21.4% | 19.6% | 23.1% | 21.8% | 21.0% | 18.1% | 21.2% | 24.8% | 22.6% | 21.2% | 24.5% | 24.9% | |
| 2.8% | 3.2% | 3.3% | 3.6% | 3.9% | 3.8% | 3.3% | 4.5% | 3.6% | 3.1% | 3.0% | 3.9% | |
| 2.8% | 3.2% | 3.3% | 3.6% | 3.9% | 3.8% | 3.3% | 4.5% | 3.6% | 3.1% | 3.0% | 3.9% | |
| 9.1% | 7.1% | 10.7% | 9.4% | 8.2% | 5.9% | 9.3% | 10.0% | 8.3% | 8.0% | 10.8% | 10.4% | |
| 8.5% | 8.3% | 8.2% | 8.0% | 7.8% | 7.4% | 7.7% | 9.1% | 9.2% | 8.8% | 9.2% | 8.9% | |
| 15.5% | 15.3% | 14.8% | 15.1% | 15.1% | 14.8% | 14.0% | 9.1% | 9.4% | 9.7% | 9.3% | 9.3% | |
| 39.2% | 38.6% | 37.3% | 37.8% | 37.8% | 36.9% | 35.0% | 30.0% | 30.9% | 31.7% | 30.4% | 30.2% | |
| 73.8% | 68.7% | 66.7% | 65.0% | 63.4% | 61.9% | 61.1% | 68.1% | 68.3% | 69.0% | 67.1% | 68.2% | |
| 14.1% | 15.0% | 13.1% | 14.5% | 14.7% | 15.4% | 13.9% | 16.1% | 16.1% | 16.8% | 14.7% | 16.7% | |
| 1.8% | 1.8% | 1.3% | 1.4% | 1.4% | 1.4% | 1.5% | 1.9% | 2.0% | 2.1% | 2.2% | 2.1% | |
| 4.6% | 5.6% | 4.9% | 5.2% | 5.1% | 5.5% | 4.8% | 5.9% | 5.1% | 6.4% | 5.6% | 6.0% | |
| 41.9% | 35.3% | 36.0% | 32.4% | 30.2% | 28.0% | 29.2% | 31.0% | 30.7% | 29.5% | 30.6% | 30.0% | |
| 26.2% | 31.3% | 33.3% | 35.0% | 36.6% | 38.1% | 38.9% | 31.9% | 31.7% | 31.0% | 32.9% | 31.8% | |
| 51.5% | 56.2% | 57.6% | 63.4% | 67.7% | 74.0% | 73.5% | 72.6% | 78.5% | 83.4% | 83.3% | 87.8% | |
| 1.3% | 1.3% | 1.3% | 1.3% | 1.3% | 1.2% | 1.1% | 1.3% | 1.3% | 1.2% | 1.2% | 1.2% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.